title: Amikacin nephrotoxicity. Incidence, clinical course and risk factors. A prospective study in a teaching hospital.
authors.forename: G
authors.initials: G
authors.lastname: Gamba
authors.forename: D
authors.initials: D
authors.lastname: Arizpe
authors.forename: H
authors.initials: H
authors.lastname: Ferral
authors.forename: A M
authors.initials: AM
authors.lastname: Contreras
authors.forename: J
authors.initials: J
authors.lastname: Cortés
authors.forename: A
authors.initials: A
authors.lastname: Mendoza
authors.forename: R
authors.initials: R
authors.lastname: Malé
authors.forename: L
authors.initials: L
authors.lastname: Viniegra
authors.forename: J C
authors.initials: JC
authors.lastname: Peña
mesh_terms: D000328:Adult; D000368:Aged; D000583:Amikacin / Q000009:adverse effects* / Q000097:blood; D003404:Creatinine / Q000097:blood; D003428:Cross Infection / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000583:Amikacin; D003404:Creatinine